3D4Medical is an award winning technology company that specialises in the development of medical, educational and health & fitness apps for professional reference as well as student and patient education.Company website
June 8, 2017
Altan is a global injectable drug company headquartered in Dublin, Ireland and committed to improving patient care by providing specialty medications of superior quality and value for the benefit of patients and caregivers.Company website
March 4, 2016
AN2H is an Irish headquartered company focused on designing novel small molecule therapeutics that target key proteins within the Ubiquitin Proteasome Pathway System (UPS).
Artizan Biosciences is a biotechnology company focused on drug discovery and development for diseases involving the human intestinal microbiota.
Cilatus BioPharma specialises in the management and services of CMC Development, CMC Regulatory Affairs, Quality Management, Engineering, Validation/Qualification and Manufacturing for biological products. Cilatus supports small, medium and large biopharma companies in strategy development, strategy execution and operations with our fully integrated team of experienced consultants.
Hatteras Venture Partners (HVP) is a life sciences focused venture capital firm based in North Carolina. HVP invests in early stage companies in life sciences with a broad focus including medical devices, diagnostics, discovery science and clinical platforms as well as healthcare IT.Company website
August 25, 2015
Immunocore is one of the world’s leading biotechnology companies, with a highly innovative immuno-oncology platform technology called ImmTACs (Immune mobilising monoclonal TCRs Against Cancer). ImmTACs are a novel class of biologic drugs based on the Company’s proprietary T cell receptor (TCR) technology, which have the potential to treat diseases with high unmet medical need including cancer, viral infections and autoimmune diseases.Company website
July 7, 2017
Jaan Health is a privately held, healthcare mobile technology company. Jaan Health has developed Phamily™ – the first mobile and web based community care coordination platform that leverages family resources intended to change patient behaviour and streamline follow-up.Company website
KNOW Bio is focused on the development of novel nitric oxide based therapies targeting a diverse range of indications.
January 26, 2017
Kymab is a biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary KymouseTM antibody platform.Company website
June 16, 2017
Melinta Therapeutics, Inc. is dedicated to saving lives threatened by the global public health crisis of bacterial infections through the development of novel antibiotics that provide new and better therapeutic solutions.Company website
June 29, 2017
NeuVT is a global medical company committed to transforming the treatment of stroke and vascular disease by designing, developing and commercialising innovative and effective interventional therapies.
Novan, Inc. is a late-stage pharmaceutical company focused on redefining the standard of care in dermatology through the development and commercialisation of innovative therapies using the Company’s nitric oxide platform.Company website
July 25, 2017
Poseida is a human therapeutics company focused on the development of novel therapies using its ground-breaking proprietary genome engineering technologies.Company website
June 5, 2017
Serenus is a specialty biopharmaceutical company, specialising in in-licensing, registering, and commercialising U.S. Food and Drug Administration, European Medicines Agency and Japan’s Pharmaceutical and Medical Devices Agency approved therapeutics to address unmet medical needs with high regional prevalence in the African market.Company website
November 16, 2015
Viamet is a drug discovery company focused on the development and commercialisation of novel small molecule drugs that target metalloenzymes via a proprietary platform called Metallophile® Technology.Company website
July 13, 2017
Wren Therapeutics is a biopharmaceutical company based in Cambridge (UK), focused on drug discovery and development for protein misfolding diseases, including major neurological and rare disorders.
Xenex aims to become the new standard method for disinfection in healthcare facilities worldwide, eliminating harmful bacteria, viruses and fungi which can cause healthcare associated infections in patients and staff. Xenex’s primary product is a patented Xenon Full Spectrum™ UV disinfection Robot which is used for the advanced disinfection of healthcare and other facilities.Company website
July 13, 2017